Deutsche Bank’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Deutsche Bank’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-500	Closed	-$4K	–	4525
2020 Q1	$4K	Sell	500 -1,176	-70%	-$11.2K	﹤0.01%	4180
2019 Q4	$17K	Buy	+1,676	New	+$16.9K	﹤0.01%	4356
2019 Q3	–	Sell	-2,900	Closed	-$33K	–	5387
2019 Q2	$33K	Buy	+2,900	New	+$55.3K	﹤0.01%	4674
2018 Q4	–	Sell	-5,834	Closed	-$155K	–	5504
2018 Q3	$155K	Sell	5,834 -275	-5%	-$8.05K	﹤0.01%	4343
2018 Q2	$181K	Buy	6,109 +1,058	+21%	+$32.5K	﹤0.01%	4329
2018 Q1	$173K	Buy	5,051 +1,551	+44%	+$64.5K	﹤0.01%	4263
2017 Q4	$150K	Buy	+3,500	New	+$175K	﹤0.01%	4135

Other funds holding CYAD

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Deutsche Bank's CYAD Position: Q2 2020 in Review

Deutsche Bank sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q2 2020, closing a stake of 500 shares — an estimated $4K sold.

Deutsche Bank first reported a position in CYAD in Q4 2017 and held it in 7 quarters. The position peaked at $181K in Q2 2018. 9 funds tracked by Wall St. Rank hold CYAD as of Q2 2020.

Deutsche Bank reported no remaining Celyad Oncology SA American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Deutsche Bank sold 500 Celyad Oncology SA American Depositary Shares shares in Q2 2020, an estimated $4K.
Deutsche Bank first reported a position in Celyad Oncology SA American Depositary Shares in Q4 2017 and held it in 7 quarters.
Deutsche Bank's Celyad Oncology SA American Depositary Shares position peaked at $181K in Q2 2018.
9 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q2 2020.

Based on Deutsche Bank's 13F filing for Q2 2020, filed 13 Aug 2020.